Molecular Targets for Combined Therapeutic Strategies to Limit Glioblastoma Cell Migration and Invasion.

aquaporin glioblastoma ion channels ionotropic glutamate receptor synaptic protein expression traditional herbal medicines transcriptomic

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2020
Historique:
received: 18 12 2019
accepted: 10 03 2020
entrez: 16 4 2020
pubmed: 16 4 2020
medline: 16 4 2020
Statut: epublish

Résumé

The highly invasive nature of glioblastoma imposes poor prospects for patient survival. Molecular evidence indicates glioblastoma cells undergo an intriguing expansion of phenotypic properties to include neuron-like signaling using excitable membrane ion channels and synaptic proteins, augmenting survival and motility. Neurotransmitter receptors, membrane signaling, excitatory receptors, and Ca

Identifiants

pubmed: 32292341
doi: 10.3389/fphar.2020.00358
pmc: PMC7118801
doi:

Types de publication

Journal Article

Langues

eng

Pagination

358

Informations de copyright

Copyright © 2020 Yool and Ramesh.

Références

Oncogene. 2004 Oct 7;23(46):7611-20
pubmed: 15361826
Pharmaceuticals (Basel). 2019 Aug 01;12(3):
pubmed: 31374984
J Neurosci. 2010 Jan 6;30(1):242-54
pubmed: 20053906
J Exp Clin Cancer Res. 2016 Feb 13;35:32
pubmed: 26872471
ACS Chem Neurosci. 2016 Mar 16;7(3):275-85
pubmed: 26711895
J Neurosci. 2008 Sep 10;28(37):9205-17
pubmed: 18784301
Front Oncol. 2019 Apr 26;9:314
pubmed: 31106149
J Pharmacol Exp Ther. 1994 Oct;271(1):25-9
pubmed: 7525924
Cold Spring Harb Perspect Biol. 2019 May 1;11(5):
pubmed: 30833454
Eur J Neurosci. 1998 Jun;10(6):2153-62
pubmed: 9753101
Nat Med. 2002 Sep;8(9):971-8
pubmed: 12172541
Neuroreport. 2017 Mar 22;28(5):259-267
pubmed: 28240721
Cell. 2003 Feb 21;112(4):519-33
pubmed: 12600315
Front Neurol. 2018 Jan 15;8:748
pubmed: 29379468
PLoS One. 2013;8(3):e58614
pubmed: 23516517
Pharmacol Biochem Behav. 2009 Nov;94(1):88-97
pubmed: 19664651
J Neurooncol. 2005 Aug;74(1):31-40
pubmed: 16078104
J Neurol Psychiatry. 1940 Apr;3(2):147-77
pubmed: 21610973
J Clin Oncol. 2009 Sep 1;27(25):4155-61
pubmed: 19636006
Int J Mol Sci. 2019 Apr 11;20(7):
pubmed: 30978987
Exp Cell Res. 2012 May 1;318(8):925-35
pubmed: 22394507
Cell Mol Life Sci. 2014 May;71(10):1839-54
pubmed: 24281762
Bone. 2001 Jul;29(1):16-23
pubmed: 11472886
Mol Neurobiol. 2016 Aug;53(6):4143-4158
pubmed: 26208698
Fitoterapia. 2011 Apr;82(3):331-41
pubmed: 21073931
J Cell Physiol. 2011 Jul;226(7):1926-33
pubmed: 21506123
Oncol Rep. 2014 Oct;32(4):1610-6
pubmed: 25050915
J Biol Chem. 2010 Apr 9;285(15):11188-96
pubmed: 20139089
J Neurosci. 1999 Jul 15;19(14):5942-54
pubmed: 10407033
Glia. 2007 Aug 1;55(10):1034-43
pubmed: 17549682
Exp Neurobiol. 2017 Jun;26(3):113-121
pubmed: 28680296
Cancer Res. 2019 Jun 15;79(12):3011-3027
pubmed: 31053634
Biol Pharm Bull. 2008 Apr;31(4):558-62
pubmed: 18379040
Life Sci. 2012 Jun 27;90(25-26):962-7
pubmed: 22634579
Nat Commun. 2018 Jan 8;9(1):81
pubmed: 29311685
Sci Transl Med. 2016 Aug 3;8(350):350fs14
pubmed: 27488893
Cancer Cell. 2010 Jan 19;17(1):98-110
pubmed: 20129251
J Neurosurg. 1988 May;68(5):698-704
pubmed: 2833587
Phytother Res. 2018 Nov;32(11):2191-2201
pubmed: 30109743
Phytother Res. 2011 Jun;25(6):916-21
pubmed: 21170924
Int J Dev Neurosci. 1993 Oct;11(5):691-7
pubmed: 8116480
Development. 2020 Jan 9;147(1):
pubmed: 31826865
Cancer Treat Res. 2010;145:67-83
pubmed: 20306246
Cell Biochem Biophys. 2015 Apr;71(3):1379-85
pubmed: 25384619
Brain. 2019 Apr 1;142(4):847-866
pubmed: 30946477
Science. 2018 May 11;360(6389):660-663
pubmed: 29748285
Nature. 2019 Sep;573(7775):532-538
pubmed: 31534219
J Cell Biol. 2003 May 26;161(4):805-16
pubmed: 12771129
Biomed Res Int. 2014;2014:260210
pubmed: 25136570
Virchows Arch A Pathol Anat Histopathol. 1987;411(1):53-9
pubmed: 3107209
Neuron. 2009 Aug 13;63(3):357-71
pubmed: 19679075
Epilepsia. 2003 Jan;44(1):46-53
pubmed: 12581229
Oncol Lett. 2013 Nov;6(5):1435-1438
pubmed: 24179537
Biomed Res Int. 2019 Feb 11;2019:9053295
pubmed: 30886866
ACS Appl Mater Interfaces. 2015 Apr 1;7(12):6674-82
pubmed: 25751368
Nutr Cancer. 2017 Aug-Sep;69(6):873-880
pubmed: 28718668
Mol Cell Proteomics. 2005 Dec;4(12):1920-32
pubmed: 16127175
Neuroscientist. 2007 Oct;13(5):470-85
pubmed: 17901256
J Gen Physiol. 2020 Jan 6;152(1):
pubmed: 31748249
Biomed Pharmacother. 2005 Aug;59(7):359-64
pubmed: 16084059
Pestic Biochem Physiol. 2016 Feb;127:76-81
pubmed: 26821661
J Surg Oncol. 2013 Dec;108(7):492-8
pubmed: 24014128
Mol Pharmacol. 2016 Oct;90(4):496-507
pubmed: 27474162
J Neurosci. 2003 Jul 2;23(13):5572-82
pubmed: 12843258
Evid Based Complement Alternat Med. 2015;2015:908493
pubmed: 26693247
Proc Natl Acad Sci U S A. 1996 May 14;93(10):4760-4
pubmed: 8643476
Neuroscience. 2004;129(4):905-13
pubmed: 15561407
BMC Complement Altern Med. 2016 Oct 6;16(1):387
pubmed: 27716341
Oncol Rep. 2016 Jan;35(1):343-51
pubmed: 26498391
Mol Pharmacol. 2012 Jan;81(1):97-105
pubmed: 22006723
Anticancer Res. 2011 Dec;31(12):4223-30
pubmed: 22199285
Nature. 2004 Nov 18;432(7015):396-401
pubmed: 15549107
J Ethnopharmacol. 2008 Nov 20;120(2):233-40
pubmed: 18790040
Neuro Oncol. 2009 Jun;11(3):260-73
pubmed: 18957620
J Neurosci. 2007 Jul 25;27(30):7987-8001
pubmed: 17652589
J Neurochem. 2008 Apr;105(2):287-95
pubmed: 18284616
Brain Res. 2019 Jul 15;1715:73-83
pubmed: 30905653
Prog Neurobiol. 2010 Aug;91(4):313-48
pubmed: 20438797
ISRN Neurol. 2011;2011:590249
pubmed: 22389824
Mol Med Rep. 2015 Sep;12(3):4592-4597
pubmed: 26082082
Phytother Res. 2012 Nov;26(11):1731-7
pubmed: 22422486
CNS Neurosci Ther. 2012 Jul;18(7):536-46
pubmed: 22530672
Front Chem. 2018 Apr 27;6:142
pubmed: 29755973
J Ethnopharmacol. 2015 Aug 2;171:264-72
pubmed: 26068424
Pharmacol Rev. 2010 Sep;62(3):405-96
pubmed: 20716669
Drug Des Devel Ther. 2015 Oct 13;9:5611-22
pubmed: 26508835
Br J Pharmacol. 2009 Apr;156(8):1185-95
pubmed: 19298256
J Pharmacol Exp Ther. 1999 Jun;289(3):1306-12
pubmed: 10336521
J Nat Prod. 2011 Dec 27;74(12):2505-13
pubmed: 22111577
Glia. 2002 Aug;39(2):162-73
pubmed: 12112367
PLoS One. 2015 Mar 12;10(3):e0114830
pubmed: 25763821
Mol Cancer Ther. 2015 Feb;14(2):355-63
pubmed: 25504754
Oncol Rep. 2011 Oct;26(4):925-30
pubmed: 21743969
Carcinogenesis. 2014 Sep;35(9):2014-24
pubmed: 24717311
Clin Exp Pharmacol Physiol. 2010 Apr;37(4):403-9
pubmed: 19566827
Molecules. 2010 Dec 07;15(12):8953-66
pubmed: 21139533
Oncol Rep. 2012 Jun;27(6):2050-6
pubmed: 22426504
PLoS One. 2011 Apr 29;6(4):e18490
pubmed: 21559510
Structure. 2006 Sep;14(9):1411-23
pubmed: 16962972
Cancer Res. 2019 Sep 15;79(18):4776-4786
pubmed: 31331912
Pharmacol Rev. 2017 Jan;69(1):1-11
pubmed: 28267675
Cancer Res. 2014 Feb 15;74(4):1238-49
pubmed: 24366881
Science. 2017 Aug 18;357(6352):
pubmed: 28818916
Neurochem Res. 2018 Mar;43(3):760-774
pubmed: 29423667
Oxid Med Cell Longev. 2013;2013:596496
pubmed: 24379902
Anticancer Res. 2015 Mar;35(3):1229-35
pubmed: 25750269
J Cancer Res Clin Oncol. 2012 Nov;138(11):1831-44
pubmed: 22722712
Cancer Chemother Pharmacol. 2017 Feb;79(2):219-225
pubmed: 27586965
Nature. 2000 May 11;405(6783):187-91
pubmed: 10821275
Invest New Drugs. 2014 Aug;32(4):604-17
pubmed: 24718901
Science. 1991 Aug 30;253(5023):1028-31
pubmed: 1653450
Food Chem Toxicol. 2013 Sep;59:657-69
pubmed: 23871826
Int J Mol Sci. 2019 Apr 12;20(8):
pubmed: 31013775
Bioorg Med Chem. 2020 Feb 15;28(4):115300
pubmed: 31937477
Acta Pharmacol Sin. 2006 Feb;27(2):179-83
pubmed: 16412267
Cell Commun Adhes. 2001;8(4-6):315-20
pubmed: 12064610
Biomol Ther (Seoul). 2017 Mar 1;25(2):186-193
pubmed: 27829269
J Cell Sci. 2001 Oct;114(Pt 20):3695-704
pubmed: 11707521
Mol Pharmacol. 2019 May;95(5):573-583
pubmed: 30858164
Nature. 2019 Sep;573(7775):539-545
pubmed: 31534222
PLoS One. 2013 Sep 09;8(9):e72882
pubmed: 24039814
Cancer Res. 2018 Nov 15;78(22):6509-6522
pubmed: 30279244
Oncotarget. 2017 Feb 7;8(6):9399-9409
pubmed: 28030799
Genes Dis. 2016 May 11;3(3):198-210
pubmed: 30258889
Sci Rep. 2019 Sep 2;9(1):12635
pubmed: 31477744
Science. 1991 Jun 21;252(5013):1715-8
pubmed: 1710829
Cancer Res. 2007 Oct 1;67(19):9463-71
pubmed: 17909056
Acta Pharmacol Sin. 2014 Jun;35(6):832-8
pubmed: 24902789
J Med Life. 2009 Oct-Dec;2(4):386-93
pubmed: 20108752
J Evid Based Complementary Altern Med. 2014 Jul;19(3):216-219
pubmed: 24789912
Life Sci. 2016 Mar 1;148:125-31
pubmed: 26845536
Biochim Biophys Acta. 2002 Jan 30;1542(1-3):209-20
pubmed: 11853893
Molecules. 2013 Feb 21;18(2):2449-57
pubmed: 23429418
Clin Cancer Res. 2005 May 1;11(9):3475-84
pubmed: 15867250
PLoS One. 2013;8(2):e56735
pubmed: 23468877
Mol Nutr Food Res. 2010 Aug;54(8):1192-201
pubmed: 20087857
Nature. 2008 Oct 23;455(7216):1061-8
pubmed: 18772890
Science. 2019 Apr 26;364(6438):
pubmed: 30872532
Oncotarget. 2015 Jul 30;6(21):18282-92
pubmed: 26286961
Neuron. 2013 Feb 6;77(3):542-58
pubmed: 23395379
Mol Pharmacol. 2000 Mar;57(3):576-88
pubmed: 10692499
Acta Neuropathol. 2007 Nov;114(5):443-58
pubmed: 17805551
J Neurosci Res. 2012 Dec;90(12):2317-27
pubmed: 22847229
Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14687-92
pubmed: 11717408
J Pharm Pharm Sci. 2015;18(4):328-38
pubmed: 26626239
Mol Pharmacol. 2016 Jan;89(1):133-40
pubmed: 26467039
Clin Transl Med. 2018 Oct 16;7(1):33
pubmed: 30327965
Int J Cancer. 2008 Sep 15;123(6):1364-75
pubmed: 18561312
Mutat Res Genet Toxicol Environ Mutagen. 2015 Nov;793:86-95
pubmed: 26520377
Oncol Rep. 2012 Oct;28(4):1435-42
pubmed: 22842701
Cancer Cell. 2015 Oct 12;28(4):429-440
pubmed: 26461091
Evid Based Complement Alternat Med. 2012;2012:703034
pubmed: 22216058
Biomed Res Int. 2017;2017:8139848
pubmed: 29181405
J Immunol. 2000 Jun 15;164(12):6509-19
pubmed: 10843709
Int J Cancer. 1999 Jul 30;82(3):435-41
pubmed: 10399962
Adv Protein Chem Struct Biol. 2016;103:203-61
pubmed: 26920691
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Cancer Treat Rev. 2005 Apr;31(2):79-89
pubmed: 15847978
Cell Death Differ. 2015 Sep;22(9):1425-36
pubmed: 25678324
Neuro Oncol. 2001 Jan;3(1):22-8
pubmed: 11305413
Mol Cancer Ther. 2010 Jan;9(1):180-9
pubmed: 20053780
Oncotarget. 2017 Feb 14;8(7):11239-11248
pubmed: 28061441
Cancer Sci. 2009 Sep;100(9):1740-7
pubmed: 19575749
Front Synaptic Neurosci. 2016 Mar 24;8:7
pubmed: 27047369
Elife. 2018 Sep 11;7:
pubmed: 30204081
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Oncogene. 2005 Oct 20;24(46):6945-56
pubmed: 16007147
Biomed Pharmacother. 2017 Jun;90:713-723
pubmed: 28419967
Eur J Neurosci. 2010 Jun;31(12):2204-20
pubmed: 20529126
eNeuro. 2019 Jan 24;6(1):
pubmed: 30680309
J Neurooncol. 2015 Jan;121(1):41-52
pubmed: 25173233
Asian Pac J Cancer Prev. 2015;16(16):7285-90
pubmed: 26514525
Science. 2019 Jan 4;363(6422):
pubmed: 30545844

Auteurs

Andrea J Yool (AJ)

Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.

Sunita Ramesh (S)

Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.
College of Science and Engineering, Flinders University, Adelaide, SA, Australia.

Classifications MeSH